IonMAN II Trial- Early Feasibility Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System
Stopped Study was not initiated in any site. Sponsor decided not to start the study
Conditions
- Coronary Stenosis
- Coronary Artery Disease
Interventions
- DEVICE: IoNIR Ridaforolimus-Eluting Coronary Stent System
Sponsor
Medinol Ltd.